Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019

Published:2022-05-16 Issue:9 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Wikström Katja¹²^ORCID,Lamidi Marja‐Leena¹,Rautiainen Päivi³^ORCID,Tirkkonen Hilkka³,Laatikainen Tiina¹²³^ORCID

Affiliation:

1. Institute of Public Health and Clinical Nutrition University of Eastern Finland Kuopio Finland

2. Department of Public Health and Welfare Finnish Institute for Health and Welfare Helsinki Finland

3. Joint Municipal Authority for North Karelia Social and Health Services Joensuu Finland

Funder

Academy of Finland

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14866

Reference22 articles.

1. Microvascular and Macrovascular Complications of Diabetes

2. Standards of medical care in diabetes‐2019;American Diabetes Association;Diabetes Care,2019

3. Type 2 Diabetes Current Care Guidelines.Working group set up by the Finnish Medical Society Duodecim the Finnish Society of Internal Medicine and the Finnish Diabetes Association 2018. Accessed September 6 2021.https://www.kaypahoito.fi/hoi50056

4. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-line pharmacotherapy intensification after metformin monotherapy in type 2 diabetes: a nationwide register study from Finland during 2011–2022;BMC Health Services Research;2024-08-19

2. Ventricular arrhythmias and haemodynamic collapse during acute coronary syndrome: increased risk for sudden cardiac death?;European Journal of Preventive Cardiology;2024-02-23

3. Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients;Frontiers in Pharmacology;2023-01-04

4. Data-Driven Identification of Long-Term Glycemia Clusters and Their Individualized Predictors in Finnish Patients with Type 2 Diabetes;Clinical Epidemiology;2023-01